 Steven Droho
Concepts (175)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Choroidal Neovascularization | 9 | 2025 | 55 | 4.950 |
Why?
| | Macrophages | 11 | 2025 | 1489 | 1.910 |
Why?
| | Choroid | 4 | 2024 | 62 | 1.650 |
Why?
| | Monocytes | 6 | 2025 | 554 | 1.080 |
Why?
| | Wet Macular Degeneration | 2 | 2023 | 45 | 0.970 |
Why?
| | Macular Degeneration | 2 | 2023 | 159 | 0.930 |
Why?
| | Flow Cytometry | 3 | 2021 | 1160 | 0.780 |
Why?
| | Interleukin-6 | 2 | 2025 | 724 | 0.730 |
Why?
| | fms-Like Tyrosine Kinase 3 | 1 | 2021 | 47 | 0.720 |
Why?
| | Dendritic Cells | 2 | 2021 | 481 | 0.710 |
Why?
| | Microglia | 5 | 2024 | 234 | 0.700 |
Why?
| | Genetic Heterogeneity | 1 | 2020 | 58 | 0.680 |
Why?
| | Mice, Inbred C57BL | 15 | 2025 | 5468 | 0.680 |
Why?
| | Propranolol | 1 | 2019 | 50 | 0.650 |
Why?
| | Phagocytes | 1 | 2020 | 97 | 0.650 |
Why?
| | Eye | 1 | 2020 | 105 | 0.640 |
Why?
| | Receptors, Adrenergic, beta | 1 | 2019 | 127 | 0.620 |
Why?
| | Fluorescein Angiography | 1 | 2019 | 143 | 0.610 |
Why?
| | Heparitin Sulfate | 1 | 2018 | 42 | 0.580 |
Why?
| | Cell-Penetrating Peptides | 1 | 2018 | 21 | 0.570 |
Why?
| | alpha-Crystallin B Chain | 1 | 2018 | 24 | 0.570 |
Why?
| | Viral Envelope Proteins | 1 | 2018 | 81 | 0.550 |
Why?
| | Mice | 21 | 2025 | 16983 | 0.520 |
Why?
| | Membrane Proteins | 2 | 2021 | 1119 | 0.490 |
Why?
| | Disease Models, Animal | 8 | 2025 | 4077 | 0.490 |
Why?
| | Retina | 4 | 2024 | 283 | 0.440 |
Why?
| | Animals | 23 | 2025 | 35409 | 0.430 |
Why?
| | Mice, Knockout | 6 | 2025 | 2888 | 0.400 |
Why?
| | Lasers | 2 | 2021 | 133 | 0.340 |
Why?
| | Visual Acuity | 2 | 2023 | 326 | 0.330 |
Why?
| | Interneurons | 4 | 2012 | 120 | 0.300 |
Why?
| | Receptors, Adrenergic, beta-2 | 1 | 2025 | 46 | 0.240 |
Why?
| | Receptors, LDL | 1 | 2025 | 47 | 0.240 |
Why?
| | Angiogenesis Inhibitors | 2 | 2023 | 218 | 0.230 |
Why?
| | Blood-Retinal Barrier | 1 | 2024 | 14 | 0.230 |
Why?
| | Intravitreal Injections | 1 | 2024 | 56 | 0.230 |
Why?
| | Retinal Degeneration | 1 | 2024 | 37 | 0.220 |
Why?
| | Mice, Transgenic | 7 | 2025 | 2135 | 0.220 |
Why?
| | Ranibizumab | 1 | 2023 | 20 | 0.220 |
Why?
| | Myeloid Cells | 1 | 2025 | 142 | 0.210 |
Why?
| | Retinal Pigment Epithelium | 2 | 2024 | 70 | 0.210 |
Why?
| | CD11c Antigen | 1 | 2023 | 41 | 0.210 |
Why?
| | Retinal Vein Occlusion | 1 | 2022 | 13 | 0.200 |
Why?
| | Epidermis | 2 | 2014 | 155 | 0.200 |
Why?
| | Spinal Cord | 3 | 2010 | 355 | 0.190 |
Why?
| | Iris | 1 | 2021 | 19 | 0.190 |
Why?
| | Retinal Diseases | 1 | 2022 | 87 | 0.180 |
Why?
| | Receptors, Interleukin-6 | 1 | 2021 | 37 | 0.180 |
Why?
| | Metformin | 1 | 2024 | 316 | 0.170 |
Why?
| | Mice, 129 Strain | 1 | 2020 | 87 | 0.170 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2023 | 528 | 0.170 |
Why?
| | Lupus Vasculitis, Central Nervous System | 1 | 2020 | 14 | 0.170 |
Why?
| | Fundus Oculi | 1 | 2019 | 61 | 0.160 |
Why?
| | Disease Susceptibility | 1 | 2021 | 334 | 0.160 |
Why?
| | Laser Therapy | 1 | 2020 | 129 | 0.150 |
Why?
| | Memory Disorders | 1 | 2020 | 162 | 0.150 |
Why?
| | Fluorescent Dyes | 1 | 2020 | 313 | 0.150 |
Why?
| | Antibodies | 1 | 2020 | 399 | 0.150 |
Why?
| | Transcriptome | 2 | 2024 | 875 | 0.140 |
Why?
| | Cricetulus | 1 | 2018 | 107 | 0.140 |
Why?
| | CHO Cells | 1 | 2018 | 155 | 0.140 |
Why?
| | Mutant Proteins | 1 | 2018 | 100 | 0.140 |
Why?
| | Cricetinae | 1 | 2018 | 280 | 0.140 |
Why?
| | Disulfides | 1 | 2018 | 97 | 0.140 |
Why?
| | Adrenergic beta-Antagonists | 1 | 2019 | 321 | 0.140 |
Why?
| | Glycosaminoglycans | 1 | 2018 | 84 | 0.140 |
Why?
| | Lupus Erythematosus, Systemic | 1 | 2020 | 247 | 0.140 |
Why?
| | Male | 10 | 2024 | 63759 | 0.130 |
Why?
| | Imaging, Three-Dimensional | 1 | 2019 | 530 | 0.130 |
Why?
| | Gene Expression Regulation | 1 | 2025 | 2545 | 0.120 |
Why?
| | Amino Acid Sequence | 2 | 2018 | 2057 | 0.120 |
Why?
| | Female | 7 | 2021 | 68829 | 0.110 |
Why?
| | Recombinant Proteins | 1 | 2018 | 1311 | 0.110 |
Why?
| | Motor Activity | 2 | 2010 | 684 | 0.110 |
Why?
| | Antimicrobial Cationic Peptides | 1 | 2014 | 77 | 0.110 |
Why?
| | Membrane Lipids | 1 | 2014 | 91 | 0.110 |
Why?
| | Biomarkers | 2 | 2022 | 3971 | 0.110 |
Why?
| | Peptide Hydrolases | 1 | 2014 | 108 | 0.100 |
Why?
| | Bungarotoxins | 1 | 2012 | 47 | 0.100 |
Why?
| | Cholinergic Antagonists | 1 | 2012 | 29 | 0.100 |
Why?
| | Brain | 1 | 2024 | 2677 | 0.090 |
Why?
| | Protein Binding | 1 | 2018 | 2123 | 0.090 |
Why?
| | Wound Healing | 1 | 2014 | 308 | 0.090 |
Why?
| | Respiration | 1 | 2012 | 193 | 0.090 |
Why?
| | Nicotinic Agonists | 1 | 2012 | 121 | 0.090 |
Why?
| | Functional Laterality | 2 | 2008 | 221 | 0.090 |
Why?
| | Burns | 1 | 2014 | 292 | 0.080 |
Why?
| | Nicotine | 1 | 2012 | 304 | 0.080 |
Why?
| | Receptors, Nicotinic | 1 | 2012 | 329 | 0.080 |
Why?
| | Skin | 1 | 2014 | 725 | 0.080 |
Why?
| | Apoptosis | 1 | 2018 | 2489 | 0.080 |
Why?
| | Transcription Factors | 5 | 2012 | 1645 | 0.070 |
Why?
| | Receptor, EphA4 | 1 | 2007 | 1 | 0.070 |
Why?
| | Recombination, Genetic | 1 | 2008 | 190 | 0.070 |
Why?
| | Gene Deletion | 1 | 2008 | 380 | 0.070 |
Why?
| | Homeodomain Proteins | 4 | 2012 | 493 | 0.060 |
Why?
| | Nuclear Receptor Subfamily 4, Group A, Member 1 | 1 | 2025 | 12 | 0.060 |
Why?
| | Receptors, CCR2 | 1 | 2025 | 40 | 0.060 |
Why?
| | Platelet Factor 4 | 1 | 2024 | 34 | 0.060 |
Why?
| | Lymphocytic Choriomeningitis | 1 | 2024 | 14 | 0.060 |
Why?
| | Lymphocytic choriomeningitis virus | 1 | 2024 | 24 | 0.060 |
Why?
| | Thrombospondin 1 | 1 | 2023 | 26 | 0.050 |
Why?
| | Animals, Newborn | 3 | 2012 | 834 | 0.050 |
Why?
| | Uveitis | 1 | 2024 | 127 | 0.050 |
Why?
| | Mice, Mutant Strains | 2 | 2020 | 298 | 0.050 |
Why?
| | Permeability | 2 | 2014 | 158 | 0.050 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2007 | 820 | 0.050 |
Why?
| | Histocompatibility Antigens Class I | 1 | 2024 | 200 | 0.050 |
Why?
| | Megakaryocytes | 1 | 2002 | 32 | 0.050 |
Why?
| | Diabetic Retinopathy | 1 | 2024 | 179 | 0.050 |
Why?
| | Inflammation | 2 | 2024 | 2748 | 0.050 |
Why?
| | Humans | 5 | 2023 | 129847 | 0.050 |
Why?
| | Light | 1 | 2024 | 363 | 0.050 |
Why?
| | Mice, Inbred BALB C | 1 | 2024 | 1248 | 0.050 |
Why?
| | Single-Cell Analysis | 1 | 2024 | 274 | 0.050 |
Why?
| | Hematopoiesis | 1 | 2002 | 184 | 0.040 |
Why?
| | Mice, Inbred ICR | 2 | 2012 | 111 | 0.040 |
Why?
| | Electrophysiological Phenomena | 2 | 2012 | 54 | 0.040 |
Why?
| | Prepulse Inhibition | 1 | 2020 | 9 | 0.040 |
Why?
| | Mice, Inbred MRL lpr | 1 | 2020 | 38 | 0.040 |
Why?
| | Maze Learning | 1 | 2020 | 101 | 0.040 |
Why?
| | In Situ Hybridization | 2 | 2012 | 296 | 0.040 |
Why?
| | Reflex, Startle | 1 | 2020 | 66 | 0.040 |
Why?
| | Association Learning | 1 | 2020 | 62 | 0.040 |
Why?
| | Gray Matter | 1 | 2020 | 81 | 0.040 |
Why?
| | Phenotype | 1 | 2007 | 3062 | 0.040 |
Why?
| | Organ Size | 1 | 2020 | 456 | 0.040 |
Why?
| | Blood-Brain Barrier | 1 | 2020 | 132 | 0.040 |
Why?
| | Carrier Proteins | 1 | 2002 | 741 | 0.040 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2024 | 855 | 0.040 |
Why?
| | Peptides | 1 | 2023 | 926 | 0.040 |
Why?
| | White Matter | 1 | 2020 | 135 | 0.040 |
Why?
| | Nuclear Proteins | 1 | 2002 | 660 | 0.030 |
Why?
| | T-Lymphocytes | 1 | 2024 | 1937 | 0.030 |
Why?
| | DNA-Binding Proteins | 1 | 2002 | 1441 | 0.030 |
Why?
| | Predictive Value of Tests | 1 | 2020 | 1951 | 0.030 |
Why?
| | Dehydration | 1 | 2014 | 49 | 0.030 |
Why?
| | Skin Absorption | 1 | 2012 | 12 | 0.020 |
Why?
| | Plethysmography, Whole Body | 1 | 2012 | 4 | 0.020 |
Why?
| | Intermediate Filament Proteins | 1 | 2012 | 57 | 0.020 |
Why?
| | Microscopy, Video | 1 | 2012 | 25 | 0.020 |
Why?
| | Medulla Oblongata | 1 | 2012 | 31 | 0.020 |
Why?
| | GATA3 Transcription Factor | 1 | 2012 | 25 | 0.020 |
Why?
| | Rhombencephalon | 1 | 2012 | 30 | 0.020 |
Why?
| | Bacterial Infections | 1 | 2014 | 234 | 0.020 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2014 | 585 | 0.020 |
Why?
| | Protein Precursors | 1 | 2012 | 128 | 0.020 |
Why?
| | Cell Count | 1 | 2012 | 318 | 0.020 |
Why?
| | Genetic Predisposition to Disease | 1 | 2020 | 2271 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2014 | 1291 | 0.020 |
Why?
| | Polymerase Chain Reaction | 1 | 2014 | 1033 | 0.020 |
Why?
| | Microscopy, Confocal | 1 | 2012 | 318 | 0.020 |
Why?
| | Data Interpretation, Statistical | 1 | 2012 | 338 | 0.020 |
Why?
| | Anterior Horn Cells | 1 | 2010 | 1 | 0.020 |
Why?
| | Nerve Net | 1 | 2012 | 260 | 0.020 |
Why?
| | Stress, Physiological | 1 | 2012 | 412 | 0.020 |
Why?
| | Membrane Potentials | 1 | 2010 | 292 | 0.020 |
Why?
| | Afferent Pathways | 1 | 2008 | 46 | 0.020 |
Why?
| | Glycine Plasma Membrane Transport Proteins | 1 | 2007 | 5 | 0.020 |
Why?
| | LIM-Homeodomain Proteins | 1 | 2007 | 13 | 0.020 |
Why?
| | Electric Stimulation | 1 | 2008 | 269 | 0.020 |
Why?
| | Glutamate Decarboxylase | 1 | 2007 | 166 | 0.020 |
Why?
| | Embryo, Mammalian | 1 | 2007 | 224 | 0.020 |
Why?
| | Luminescent Proteins | 1 | 2007 | 176 | 0.020 |
Why?
| | Axons | 1 | 2007 | 193 | 0.020 |
Why?
| | Psychomotor Performance | 1 | 2008 | 312 | 0.020 |
Why?
| | Motor Neurons | 1 | 2007 | 233 | 0.010 |
Why?
| | Erythroid-Specific DNA-Binding Factors | 1 | 2002 | 18 | 0.010 |
Why?
| | GATA1 Transcription Factor | 1 | 2002 | 18 | 0.010 |
Why?
| | GATA2 Transcription Factor | 1 | 2002 | 14 | 0.010 |
Why?
| | Zinc Fingers | 1 | 2002 | 44 | 0.010 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2002 | 363 | 0.010 |
Why?
| | Amino Acid Substitution | 1 | 2002 | 284 | 0.010 |
Why?
| | Base Sequence | 1 | 2002 | 2142 | 0.010 |
Why?
| | Molecular Sequence Data | 1 | 2002 | 2833 | 0.010 |
Why?
|
|
Droho's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|